XTX Topco’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,948
Closed -$346K 4156
2025
Q4
$346K Buy
+11,948
New +$227K 0.01% 1947
2025
Q1
Sell
-2,541
Closed -$90.8K 2825
2024
Q4
$90.8K Sell
2,541
-11,349
-82% -$587K 0.01% 1786
2024
Q3
$656K Buy
13,890
+9,033
+186% +$399K 0.05% 633
2024
Q2
$244K Buy
4,857
+3,515
+262% +$254K 0.02% 1091
2024
Q1
$150K Buy
+1,342
New +$133K 0.02% 1262
2023
Q4
Sell
-3,169
Closed -$101K 1912
2023
Q3
$101K Buy
+3,169
New +$151K 0.02% 1183
2023
Q2
Sell
-1,830
Closed -$188K 1666
2023
Q1
$188K Sell
1,830
-3,486
-66% -$489K 0.04% 977
2022
Q4
$779K Buy
5,316
+2,782
+110% +$470K 0.17% 140
2022
Q3
$428K Buy
2,534
+985
+64% +$160K 0.11% 305
2022
Q2
$179K Buy
1,549
+1,146
+284% +$108K 0.07% 495
2022
Q1
$40K Sell
403
-63
-14% -$7.36K 0.02% 608
2021
Q4
$72K Buy
+466
New +$90.7K 0.04% 520
2021
Q3
Sell
-582
Closed -$197K 927
2021
Q2
$197K Buy
+582
New +$220K 0.07% 570

Other funds holding MRSN